Literature DB >> 18837738

Effect of Helicobacter pylori eradication on oncogenes and cell proliferation.

Y Zhu1, X Shu, J Chen, Y Xie, P Xu, D-Q Huang, N-H Lu.   

Abstract

BACKGROUND: Helicobacter pylori , the main cause of chronic gastritis, is a class 1 gastric carcinogen. However, it remains unclear whether H. pylori affects molecular alterations in chronic gastritis. Thus, this study was designed to investigate the effect of H. pylori eradication on the expression of human telomerase RNA (hTR), human telomerase reverse transcriptase (hTERT), c-myc and proliferation nuclear cell antigen (PCNA) in H. pylori associated chronic gastritis.
MATERIALS AND METHODS: hTR was determined by in situ hybridization, hTERT, c-myc and PCNA were detected by immunohistochemistry using stomach tissues obtained from 39 H. pylori-infected and 21 H. pylori-negative patients with chronic gastritis before and after H. pylori eradication therapy or treatment for symptom relief only.
RESULTS: Levels of hTR, hTERT, c-myc and PCNA were significantly higher in H. pylori-infected mucosa (51.3%, 53.8%, 53.8% and 16.8 +/- 5.8, respectively) when compared to H. pylori-negative mucosa before therapy (19.0%, 23.8%, 28.6%, 8.8 +/- 3.4, respectively; P < 0.05 in all cases). In patients with successful eradication of H. pylori the levels of hTR, hTERT, c-myc and PCNA (55.5%, 59.3%, 59.3%, 16.8 +/- 5.8, respectively) were significantly reduced after the therapy (22.2%, 22.2%, 14.8%, 7.0 +/- 5.0, respectively; P < 0.05 in all cases). In the H. pylori failed eradication and H. pylori-negative groups, there was no statistical difference in all four measurements.
CONCLUSIONS: H. pylori infection may induce the overexpression of hTR, hTERT, c-myc and stimulate cell proliferation. Eradication of H. pylori may reverse the aberrant expression of these oncoproteins and thus correct the abnormal cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18837738     DOI: 10.1111/j.1365-2362.2008.01987.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

Review 1.  Gastric cancer development after the successful eradication of Helicobacter pylori.

Authors:  Kaname Uno; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

2.  The role of oncogenes in gastrointestinal cancer.

Authors:  Emmanouil P Pappou; Nita Ahuja
Journal:  Gastrointest Cancer Res       Date:  2010-11

3.  Potential effect of chronic Helicobacter pylori infection on glucose metabolism of Mongolian gerbils.

Authors:  Zhen Yang; Wei Li; Cong He; Chuan Xie; Yin Zhu; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis.

Authors:  Ze-Min Yang; Wei-Wen Chen; Ying-Fang Wang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

Review 5.  Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma.

Authors:  Mohammad Shadifar; Ramin Ataee; Amin Ataie; Ali Morad Heydari Gorgi; Nafiseh Nasri Nasrabadi; Somayyeh Nouri
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

6.  Phosphorylation and inactivation of PTEN at residues Ser380/Thr382/383 induced by Helicobacter pylori promotes gastric epithelial cell survival through PI3K/Akt pathway.

Authors:  Zhen Yang; Chuan Xie; Wenting Xu; Gongmeizi Liu; Ximei Cao; Wei Li; Jiang Chen; Yin Zhu; Shiwen Luo; Zhijun Luo; Nonghua Lu
Journal:  Oncotarget       Date:  2015-10-13

7.  Phosphorylation of phosphatase and tensin homolog induced by Helicobacter pylori promotes cell invasion by activation of focal adhesion kinase.

Authors:  Zhen Yang; Ximei Cao; Wenting Xu; Chuan Xie; Jiang Chen; Yin Zhu; Nonghua Lu
Journal:  Oncol Lett       Date:  2017-11-16       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.